Senior HEOR Manager

The Position

Are you passionate about innovation, finding cutting-edge solutions and creating value where it matters, around the globe? At the BI global Inflammation team, we strive to deliver innovative Therapeutic and patient centric solutions by putting the patient in the center of everything we do. We foster innovative thinking as well as an agile and collaborative way of working to advance our novel programs and capabilities in Therapeutic Area Inflammation.

The Global TA Inflammation, (Senior) HEOR Manager, brings technical expertise, driving Outcomes Research (HEOR) and Patient Related Outcomes fostering our patient centric drive. His/her role involves supporting the TA Market Access Head by providing oversight, direction, and functional support on HEOR & PRO & Access projects, working closely with Value and Evidence Networks within our Global Business Unit and with external stakeholders.

Tasks & responsibilities

• In your new role, you develop and execute on health economics outcomes research (HEOR) & PRO strategies, demonstrating the medical and economic payer-relevant needs to optimize value of BI products.
• Generate evidence that secures optimal market access, successful HTA assessments, optimal pricing, reimbursement, and formulary listing for BI products on a global scale.
• Ensure insights to further inform development of the Target Product Profile (TPP) and clinical development plan of our pipeline compounds.
• Ensure relevant and new patient-reported outcome (PRO) measurement strategies to capture the patient perspective in our clinical trial program, and interact with regulatory authorities, closely collaborating with other functions.
• Ensure efficient and timely development of key HEOR deliverables (i.e., payer value stories, payer engagement tools, GVDs, economic models, retrospective database analyses, indirect comparisons, real world evidence data) for assigned BI products.
• Develop and maintain partnerships with payers, academic research institutions, contract research organizations, and other HEOR thought leaders to optimize the impact of HEOR & PRO research.

Additional responsibilities as Senior Manager:

• Define long-term global development strategies for the assets, in close collaboration with global Marketing and global Medical counterparts, to ensure optimal patient access.
• Draft long-term publication strategies, considering the long-term global market development.

Requirements

• Graduate degree, preferably PhD in health economics, Medicine (MD), public health, pharmacy, focusing on Health Technology Assessment, PRO, Pharmacy, Medicine, Public Health.
• Several years of pharma industry experience, with positions in areas relevant for HEOR, PRO consulting or payer authorities.
• Multiple years of direct experience undertaking Health Technology Assessments (HTA) & PRO including evaluations for Regulatory and health authority interventions of pharmaceutical products.
• Conducting or being part of a team working on non-interventional studies and RWE programs.
• Demonstrated experience of successful regulatory, reimbursement negotiations for launching new products in key markets.
• Proven track record of delivering value demonstration materials that resulted in timely patient access and adoption.
• Proven ability in appraising clinical evidence (both RCTs and operational evidence).
• Profound knowledge and expertise in formulating COA strategies including validation methods, administration of measures and statistical analyses of COA data.
• Excellent communication and influencing skills in both internal and external contexts.

Additional requirements as Senior HEOR Manager:

• Long-term pharma industry experience, with positions in the areas of health economics, pricing & reimbursement, consulting, or payer authorities.
• Several years of exposure to international business on a day-to-day basis.
• Strong track record in value generation, demonstration and/or communication.
• Highly experienced in conducting health economics/outcomes research across multiple specialty disciplines (e.g., patient reported outcomes, health economic modelling, real world data generation).